18 December 2024

Obesity Public Health Smoking

Smoking overtaken as No 1 contributor to disease burden

18 December 2024

Diabetes Obesity

Even more things GLP-1 RAs can do

21 November 2024

Diabetes Obesity

Tirzepatide safe, highly effective for three years

26 September 2024

Obesity Paediatric

Obese kids risk eczema, psoriasis, alopecia

29 August 2024

Diabetes Obesity

‘Exciting’ discovery on metabolic disease triggers

29 August 2024

Obesity Pharmaceuticals Surgery

Bariatric surgery declining amid rise of GLP-1 RAs

18 July 2024

Diabetes Obesity

Tirzepatide beats semaglutide for weight loss

4 July 2024

Diabetes Obesity Political TGA

First generic GLP-1 RAs in the approval pipeline

6 June 2024

Diabetes PBS Political

PBS rejigs rules on GLP-1s and other diabetes meds

23 May 2024

Diabetes Obesity Pharmacy Political

Ozempic compounded in ‘disgusting’ conditions

23 May 2024

Diabetes Obesity Political TheHill

Butler slaps ban on compounded semaglutide and tirzepatide

28 March 2024

Exercise Obesity Pharmaceuticals

Exercise beats GLP-1 RAs for keeping weight off

27 July 2023

Obesity

Don’t mention the (obesity) war?

23 February 2023

Obesity

Obesity and diabetes: is air quality to blame?

23 February 2023

Obesity Pharmaceuticals Political

Who deserves Ozempic, anyway?

16 February 2023

Mental Health Obesity

Suicide and liver risk after bariatric surgery